Group Members

Group Leader

Anna Martner, PhD, Associate Professor

PhD, University of Gothenburg, 2009

Post doc, Moffitt Cancer Center, Tampa, 2011-2012

PI, Sahlgrenska Center for Cancer Research, 2012-

Our research projects focus on tumor immunology with a clear translational approach. Novel treatment strategies are evaluated in vitro, using primary tumor cells, and in mouse models, including in xenografted humanized mice. We also perform immune monitoring in clinical trials of myeloid leukemia and melanoma, including trials using the NOX2-inhibitor histamine dihydrochloride (Ceplene).

Postdoctoral Researchers

Roberta Kiffin, PhD

PhD in Medicine, Albert Einstein College of Medicine, NY, 2011

Post doc at Institute for Research in Biomedicine, Barcelona, 2011-2012

Post doc, Sahlgrenska Center for Cancer Research, University of Gothenburg, 2014-

Dr. Kiffin’s research seeks to improve treatment of acute myeloid leukemia and melanoma by defining mechanisms of action and immunological effects of currently approved therapies in these diseases. Her previous research has focused on understanding how alterations in autophagy affect human health.

Hanna Grauers Wiktorin, PhD

MSc in Biotechnology, Chalmers University of Technology, 2014

PhD in Medicine, Sahlgrenska Cancer Center, University of Gothenburg 2018

Post doc, Sahlgrenska Center for Cancer Research, University of Gothenburg, 2018-

Dr. Grauers Wiktorin studies the regulation and impact of redox reactions in cancer. Her studies involve dual targeting of the NOX2-enzyme and check point inhibitors of PD-1.

Mohammad Arabpour, PhD

PhD in Gene Therapy, University of Groningen, Netherlands, 2016

Post doc, MIVAC, University of Gothenburg, 2016-2019

Post doc, Sahlgrenska Center for Cancer Research, University of Gothenburg, 2019-

Dr. Arabpour has extensive experience of contruction of fusion-proteins and vaccines. He is currently focusing on development of T cell targeted anti-tumoral vaccines.

Belson Rugwizangoga ,MD, PhD

Medical Doctor, University of Rwanda, Butare 2007

PhD-student, Sahlgrenska Center for Cancer Research, 2015-

Dr. Rugwizangoga conducted his PhD-studies in the Martner lab. His studies involves characterization of acute leukemias in Rwanda, including possible connections between malaria, EBV infection and subtypes of leukemia.

PhD Students

Malin Nilsson, MSc

MSc in Biotechnology, Chalmers University of Technology, 2016

PhD-student, Sahlgrenska Center for Cancer Research, 2016-

Malin Nilsson’s research is focused on single cell transcriptional profiling of leukemic stem cells and evaluation of anti-cancer efficacy of bi-specific antibodies in vitro and in vivo.

Sanchari Paul, MSc

MSc in Biotechnology, Chalmers University of Technology, 2017

PhD-student, Sahlgrenska Center for Cancer Research, 2018-

The research project of Sanchari Paul aims at identifying and expanding tumor-specific T cells for therapeutic purposes.

Andreas Törnell, MSc

MSc in Biotechnology, Chalmers University of Technology, 2020

PhD-student, Sahlgrenska Center for Cancer Research, 2020-

Andreas Törnell is studying the role of NOX2 SNPs for the development and progression of neurological disesase

Former Group Members

Junko Johansson, PhD

MSc in Biotechnology, Chalmers University of Technology, 2014

PhD-student, Sahlgrenska Center for Cancer Research, 2015-2019

Post doc, Sahlgrenska Center for Cancer Research, 2019-

The PhD-project of Junko Johansson was a collaboration between the Martner lab and the Surgery Department at Sahlgrenska University Hospital. The project aimed at defining the role of immunity for the clinical response to isolated limb perfusion using melphalan in melanoma. The post doc studies of Junko Johansson focus on exosomes in malignant melanoma.

Ebru Aydin, PhD

MSc in Immunology & Infection Biology, Uppsala University, 2013

PhD, Sahlgrenska Center for Cancer Research, University of Gothenburg, 2018

Post doc at the German Cancer Research Center, Heidelberg, 2019-

Ebru Aydin performed her PhD-studies in the Martner lab on research defining the role of NOX2 for anti-tumor immune effector mechanisms in melanoma and in leukemia. At present she is conducting a post doc in Heidelberg that focuses on T cell responses during Pancreatic cancer.

<span>%d</span> bloggers like this: